| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Cecil H. and Ida Green Center for Reproductive Biology Sciences (T.S., Y.Z., E.R.S.), Dallas, Texas 75235-9051; and the Departments of Obstetrics/Gynecology, Biochemistry (T.S., Y.Z., E.R.S.), and The Howard Hughes Medical Institute and Department of Pharmacology (D.J.M.), The University of Texas Southwestern Medical Center, Dallas, Texas 75235-9038
Address all correspondence and requests for reprints to: Tiejun Sun, M.D., Ph.D., Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9038.
The biosynthesis of estrogens is catalyzed by aromatase P450
(P450arom), the product of the CYP19 gene. The
tissue-specific expression of the CYP19 gene is regulated by means of
tissue-specific promoters through the use of alternative splicing
mechanisms. Thus, transcripts containing various 5'-untranslated
termini are present in ovary, brain, adipose stromal cells, and
placenta. Sequence corresponding to untranslated exon I.1 is present
uniquely in 5'-termini of transcripts expressed in human placenta and
choriocarcinoma cells, as a consequence of expression driven by a
distal promoter, I.1. The goal of the present study was the
identification of regulatory elements in this promoter region. Various
deletion mutations of the upstream flanking region of exon I.1 were
constructed using the PCR or restriction enzyme digestion. The genomic
fragments were fused upstream of the luciferase reporter gene. These
constructs were transfected into human choriocarcinoma (JEG3) cells.
The longest construct employed, -924/+10 bp, expressed the highest
luciferase reporter gene activity. The -64/+10 bp and -125/+10 bp
constructs showed no reporter gene expression. Transfection of the
-201/+10 bp construct resulted in reporter gene expression, but at a
lower level than that of the -924/+10 bp construct, and this
expression was induced by serum as well as by LG69 and TTNPB, ligands
specific for RXR and RAR respectively, as well as by vitamin D. These
results parallel the actions of the ligands on aromatase activity.
Mutation or deletion of an imperfect palindromic sequence
(AGGTCATGCCCC) located at -183 to -172 bp upstream of the
transcriptional start site of exon I.1 resulted in loss of basal- and
retinoid-induced reporter gene expression. Gel retardation analysis
using nuclear extracts of JEG3 cells treated with retinoids and the
imperfect palindromic sequence as probe, showed that proteins present
in the nuclear extracts bound to this sequence in a specific fashion.
The binding activities were elevated by incubation of the cells with
LG69 and TTNPB, ligands specific for RXR and RAR respectively. Binding
of nuclear proteins to the palindromic sequence was displaced either by
anti-RXR
serum or by anti-VDR serum, suggesting the formation of a
heterodimer of RXR
and VDR. These results suggest that the imperfect
palindromic sequence upstream of exon I.1 plays an important but novel
role in the regulated expression of the CYP19 gene in choriocarcinoma
cells.
This article has been cited by other articles:
![]() |
T. Nakanishi, J.-i. Nishikawa, Y. Hiromori, H. Yokoyama, M. Koyanagi, S. Takasuga, J.-i. Ishizaki, M. Watanabe, S.-i. Isa, N. Utoguchi, et al. Trialkyltin Compounds Bind Retinoid X Receptor to Alter Human Placental Endocrine Functions Mol. Endocrinol., October 1, 2005; 19(10): 2502 - 2516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Ellem, J. F. Schmitt, J. S. Pedersen, M. Frydenberg, and G. P. Risbridger Local Aromatase Expression in Human Prostate Is Altered in Malignancy J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2434 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kovacic, C. J. Speed, E. R. Simpson, and C. D. Clyne Inhibition of Aromatase Transcription Via Promoter II by Short Heterodimer Partner in Human Preadipocytes Mol. Endocrinol., January 1, 2004; 18(1): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kinoshita and S. Chen Induction of Aromatase (CYP19) Expression in Breast Cancer Cells through a Nongenomic Action of Estrogen Receptor {alpha} Cancer Res., July 1, 2003; 63(13): 3546 - 3555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huening, G. Yehia, C. A. Molina, and S. Christakos Evidence for a Regulatory Role of Inducible cAMP Early Repressor in Protein Kinase A-Mediated Enhancement of Vitamin D Receptor Expression and Modulation of Hormone Action Mol. Endocrinol., September 1, 2002; 16(9): 2052 - 2064. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose Endocrinology, August 1, 2002; 143(8): 2863 - 2871. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Clyne, C. J. Speed, J. Zhou, and E. R. Simpson Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes J. Biol. Chem., May 31, 2002; 277(23): 20591 - 20597. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Blanchon, P. Sauvant, C. Bavik, D. Gallot, F. Charbonne, M.-C. Alexandre-Gouabau, D. Lemery, B. Jacquetin, B. Dastugue, S. Ward, et al. Human choriocarcinoma cell line JEG-3 produces and secretes active retinoids from retinol Mol. Hum. Reprod., May 1, 2002; 8(5): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kinuta, H. Tanaka, T. Moriwake, K. Aya, S. Kato, and Y. Seino Vitamin D Is an Important Factor in Estrogen Biosynthesis of Both Female and Male Gonads Endocrinology, April 1, 2000; 141(4): 1317 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Rubin, Y. Zhao, A. M. Kalus, and E. R. Simpson Peroxisome Proliferator-activated Receptor {{gamma}} Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy Cancer Res., March 1, 2000; 60(6): 1604 - 1608. [Abstract] [Full Text] |
||||
![]() |
K. Yamada, H. Ogawa, S.-i. Honda, N. Harada, and T. Okazaki A GCM Motif Protein Is Involved in Placenta-specific Expression of Human Aromatase Gene J. Biol. Chem., November 5, 1999; 274(45): 32279 - 32286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamat, J. L. Alcorn, C. Kunczt, and C. R. Mendelson Characterization of the Regulatory Regions of the Human Aromatase (P450arom) Gene Involved in Placenta-Specific Expression Mol. Endocrinol., November 1, 1998; 12(11): 1764 - 1777. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |